{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:57:00Z","timestamp":1787540220819,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012483","name":"University of Georgia Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cellimm.2021.104304","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T03:15:52Z","timestamp":1612926952000},"page":"104304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Residual immune activation in HIV-Infected individuals expands monocytic-myeloid derived suppressor cells"],"prefix":"10.1016","volume":"362","author":[{"given":"Ritesh","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouli","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman K.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-6138","authenticated-orcid":false,"given":"Ankita","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2021.104304_b0005","doi-asserted-by":"crossref","unstructured":"I.S.S. Group, J.D. Lundgren, A.G. Babiker, F. Gordin, S. Emery, B. Grund, S. Sharma, A. Avihingsanon, D.A. Cooper, G. Fatkenheuer, J.M. Llibre, J.M. Molina, P. Munderi, M. Schechter, R. Wood, K.L. Klingman, S. Collins, H.C. Lane, A.N. Phillips, J.D. Neaton, Initiation of antiretroviral therapy in early asymptomatic HIV infection, N. Engl. J. Med., 373 (2015) 795-807.","DOI":"10.1056\/NEJMoa1506816"},{"key":"10.1016\/j.cellimm.2021.104304_b0010","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2021.104304_b0015","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"When To Start","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2021.104304_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.cellimm.2021.104304_b0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COH.0000000000000242","article-title":"Role of immune activation in progression to AIDS","volume":"11","author":"Utay","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0030","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1089\/088922202320935429","article-title":"Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy","volume":"18","author":"Almeida","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cellimm.2021.104304_b0035","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2021.104304_b0040","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2021.104304_b0045","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2021.104304_b0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jit469","article-title":"HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity","volume":"209","author":"Garg","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2021.104304_b0055","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/JVI.01759-12","article-title":"Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals","volume":"87","author":"Qin","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2021.104304_b0060","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1097\/QAD.0b013e328354b43f","article-title":"Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells","volume":"26","author":"Vollbrecht","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0070","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellimm.2021.104304_b0085","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-09-3767","article-title":"Immature immunosuppressive CD14+HLA-DR-\/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign","volume":"70","author":"Poschke","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104304_b0090","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104304_b0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.24700","article-title":"Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species","volume":"55","author":"Tacke","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2021.104304_b0100","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1479-5876-9-90","article-title":"Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines","volume":"9","author":"Lechner","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellimm.2021.104304_b0110","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.2006.08.5829","article-title":"Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine","volume":"25","author":"Filipazzi","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2021.104304_b0115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.intimp.2011.01.003","article-title":"Myeloid derived suppressor cells in human diseases","volume":"11","author":"Greten","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2021.104304_b0120","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0125","doi-asserted-by":"crossref","first-page":"44485","DOI":"10.1038\/srep44485","article-title":"Human immunodeficiency virus type-1 myeloid derived suppressor cells inhibit cytomegalovirus inflammation through interleukin-27 and B7\u2013H4","volume":"7","author":"Garg","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2021.104304_b0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","article-title":"Myeloid-derived suppressor cell heterogeneity and subset definition","volume":"22","author":"Peranzoni","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.176.1.284","article-title":"Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression","volume":"176","author":"Bunt","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0140","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.181.7.4666","article-title":"Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells","volume":"181","author":"Sinha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0145","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.4049\/jimmunol.169.6.3180","article-title":"CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis","volume":"169","author":"Mencacci","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/mi.2012.62","article-title":"STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia","volume":"6","author":"Poe","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0155","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/eji.201040911","article-title":"Myeloid-derived suppressor cells in parasitic infections","volume":"40","author":"Van Ginderachter","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/COH.0000000000000234","article-title":"Microbial translocation and microbiome dysbiosis in HIV-associated immune activation","volume":"11","author":"Zevin","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003829","article-title":"A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects","volume":"10","author":"Mutlu","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2021.104304_b0170","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2021.104304_b0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mi.2010.22","article-title":"IL-22 defines a novel immune pathway of antifungal resistance","volume":"3","author":"De Luca","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0180","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/mi.2012.72","article-title":"A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis","volume":"5","author":"Kim","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0185","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ni.2089","article-title":"IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium","volume":"12","author":"Ota","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0195","doi-asserted-by":"crossref","unstructured":"J. Grarup, C. Rappoport, N.W. Engen, C. Carey, F. Hudson, E. Denning, S. Sharma, E. Florence, M.J. Vjecha, H.I.V.T.S.S.G. International Network for Strategic Initiatives in Global, Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial, HIV Med, 16 Suppl 1 (2015) 14-23.","DOI":"10.1111\/hiv.12229"},{"key":"10.1016\/j.cellimm.2021.104304_b0200","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1089\/aid.2005.21.1066","article-title":"Analysis of HIV type 1 subtype C full-length gag gene sequences from India: novel observations and plausible implications","volume":"21","author":"Gupta","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cellimm.2021.104304_b0205","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1089\/088922299310656","article-title":"Subtypes of HIV type 1 circulating in India: partial envelope sequences","volume":"15","author":"Maitra","year":"1999","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cellimm.2021.104304_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039819","article-title":"Molecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C","volume":"7","author":"Neogi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2021.104304_b0215","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1128\/JCM.00880-13","article-title":"Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States","volume":"51","author":"Pyne","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cellimm.2021.104304_b0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1189\/jlb.1111579","article-title":"Expansion of a subset of CD14highCD16negCCR2low\/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection","volume":"91","author":"Gama","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2021.104304_b0225","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/QAD.0000000000000871","article-title":"In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3zeta expression through ELF-1 inhibition","volume":"29","author":"Tumino","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0230","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/QAD.0000000000001083","article-title":"Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals","volume":"30","author":"Wang","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0235","first-page":"457","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2021.104304_b0240","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/jvi.69.9.5337-5344.1995","article-title":"C\/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages\/monocytes","volume":"69","author":"Henderson","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2021.104304_b0245","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1073\/pnas.0807269105","article-title":"NF-IL6 (C\/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G","volume":"105","author":"Kinoshita","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2021.104304_b0250","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/INF.0b013e3181ed9f4c","article-title":"Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy","volume":"29","author":"Cervia","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cellimm.2021.104304_b0255","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/QAD.0b013e3283471f10","article-title":"I.S.s. group, Resumption of HIV replication is associated with monocyte\/macrophage derived cytokine and chemokine changes: results from a large international clinical trial","volume":"25","author":"Cozzi-Lepri","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0260","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-15-2463","article-title":"Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs)","volume":"22","author":"Alfaro","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104304_b0265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clim.2012.06.003","article-title":"On the armament and appearances of human myeloid-derived suppressor cells","volume":"144","author":"Poschke","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006395","article-title":"Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques","volume":"13","author":"Sui","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2021.104304_b0275","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/QAD.0000000000000735","article-title":"Soluble CD14 is a nonspecific marker of monocyte activation","volume":"29","author":"Shive","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.cellimm.2021.104304_b0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2021.104304_b0285","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/mi.2016.38","article-title":"IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice","volume":"10","author":"Moyat","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cellimm.2021.104304_b0290","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-13-230","article-title":"Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study","volume":"13","author":"Knudsen","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"#cr-split#-10.1016\/j.cellimm.2021.104304_b0295.1","unstructured":"B.R. Krishnan S, Rodriguez B, et al., Smoking and Obesity May Partially Explain the Inflammation and Morbidity Association, In: in the Program and Abstracts of the 2015 Conference on Retroviruses and Opportunistic Infections"},{"key":"#cr-split#-10.1016\/j.cellimm.2021.104304_b0295.2","unstructured":"Seattle, WA. Abstract #763., (2015)."},{"key":"10.1016\/j.cellimm.2021.104304_b0300","doi-asserted-by":"crossref","unstructured":"K.K. Singh, S. Nathamu, A. Adame, T.U. Alire, W. Dumaop, B. Gouaux, D.J. Moore, E. Masliah, H.I.V.N.R.C.G. and, Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS, Neurobehav HIV Med, 3 (2011) 41-52.","DOI":"10.2147\/NBHIV.S19969"},{"key":"10.1016\/j.cellimm.2021.104304_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.10.008","article-title":"Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications","volume":"45","author":"Hong","year":"2015","journal-title":"Brain Behav. Immun."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492100023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492100023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:07:32Z","timestamp":1757804852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492100023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":62,"alternative-id":["S000887492100023X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104304","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual immune activation in HIV-Infected individuals expands monocytic-myeloid derived suppressor cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104304"}}